,i #aagth ,,congress #ast ,session ,h4 ,r4 #ebbd ,,in ,,the ,,house ,,of ,,representatives ,september #aj1 #bjba,mr4 ,hill 7for himself and ,mrs4 ,dingell7 introduced the following bill2 which was referred to the ,committee on ,energy and ,commerce ,a ,,bill ,to amend the ,public ,health ,service ,act to authorize grants to eligible entities to develop strategic response plans with respect to the opioid crisis1 and to require health care practitioners prescribing an opioid for certain patients to also prescribe an opioid overdose reversal drug1 and for other purposes4 #a4 ,short title ,this ,act may be cited as the ,preventing ,overdoses and ,saving ,lives ,act of #bjba4 #b4 ,state demonstration grants for comprehensive opioid abuse data ,title ,,iii of the ,public ,health ,service ,act 7#db ,u4,s4,c4 #bda et seq47 is amended by inserting after section #cag,u of such ,act 7#db ,u4,s4,c4 #bdg;b-#bc7 the following3 #cag,v4 ,state demonstration grants for comprehensive opioid abuse data 7a7 ,in general ,the ,secretary1 in conjunction with the ,director of the ,centers for ,disease ,control and ,prevention1 may award grants to eligible entities-- 7#a7 to conduct research and develop a strategic response plan with respect to the opioid crisis2 and 7#b7 to establish and implement a co-prescribing program4 7b7 ,amount of grants 7#a7 ,in general ,the ,secretary shall determine the amount of each grant awarded under this section on an annual basis4 ,in allocating such amounts across grantees for a fiscal year1 the ,secretary shall award-- 7,a7 a minimum amount to each grantee in accordance with paragraph 7#b72 and 7,b7 an additional amount to each grantee in accordance with paragraph 7#c74 7#b7 ,minimum amount ,the ,secretary shall-- 7,a7 determine the basis for determining the minimum amount of a grant under paragraph 7#a77;,a72 and 7,b7 apply such basis consistently across all grantees under this section4 7#c7 ,additional amount ,in allocating additional amounts across all grantees under this section for a fiscal year1 the ,secretary shall give priority in setting such amounts to grantees with the highest opioid dispensing rates as determined by the ,centers for ,disease ,control and ,prevention4 7c7 ,priority in selection ,in selecting grantees under this section1 the ,secretary shall give priority to eligible entities with the highest opioid dispensing rates as determined by the ,centers for ,disease ,control and ,prevention4 7d7 ,allocation of funds by a grantee ,a grantee under this section shall allocate the funds received through the grant as follows3 7#a7 ,not more than #hj percent of the funds received through the grant shall be used to conduct research and develop a strategic plan in accordance with subsection 7e74 7#b7 ,at least #bj percent of the grant shall be used by the grantee to administer a co-prescribing program in accordance with subsection 7f74 7e7 ,research2 strategic plan 7#a7 ,in general ,subject to subsection 7d71 a grantee under this section shall use the grant funds-- 7,a7 to conduct research on the impacts of the opioid crisis within the jurisdiction of the grantee2 and 7,b7 to develop a strategic plan to respond to the opioid crisis within such jurisdiction4 7#b7 ,strategic plan contents ,a strategic plan required by paragraph 7#a77;,b7 shall include plans for-- 7,a7 increasing public awareness about the opioid crisis within the jurisdiction of the grantee2 7,b7 full-spectrum prevention within such jurisdiction2 7,c7 intervention within such jurisdiction2 7,d7 treatment and recovery within such jurisdiction2 and 7,e7 coordinating with law enforcement within such jurisdiction4 7f7 ,co-,prescribing program 7#a7 ,in general ,subject to subsection 7d71 a grantee under this section shall use funds received through the grant to carry out a co-prescribing program under which the grantee requires-- 7,a7 health care practitioners in the jurisdiction of the grantee who prescribe an opioid for any patient to also prescribe an opioid overdose reversal drug for such patient if-- 7i7 the opioid dosage prescribed is equal to or in excess of #ej morphine milligram equivalents per day2 7ii7 the practitioner prescribes a benzodiazepine for the patient or knows or reasonably should know a benzodiazepine has been prescribed for the patient in the past2 7iii7 the practitioner prescribes medication-assisted treatment for the patient or knows or reasonably should know medication assisted treatment has been prescribed for the patient in the past2 or 7iv7 the practitioner knows or reasonably should know the patient has a history of substance use disorder2 7,b7 such health care practitioners to complete continuing education on opioid prescribing2 and 7,c7 coroners in the jurisdiction of the grantee to complete continuing education on recognizing fatalities attributable to an opioid overdose4 7#b7 ,waiver ,if the laws1 regulations1 or orders of an applicant for a grant under this section conflict in any respect with the requirements of subparagraph 7,a71 7,b71 or 7,c7 of paragraph 7#a71 the ,secretary shall waive such requirements to the extent necessary to allow the grantee to carry out a co-prescribing program under this section4 7g7 ,supplement1 not supplant ,grant funds under this section shall be used to supplement1 not supplant1 funding from other sources for the activities funded through the grant4 7h7 ,application ,to seek a grant under this section1 an eligible entity shall submit an application at such time1 in such manner1 and containing such information and assurances as the ,secretary may require4 7i7 ,reporting ,not later than the end of each of fiscal years #bjbd and #bjbf1 a grantee under this section shall submit to the ,secretary1 the ,director of the ,centers for ,disease ,control and ,prevention1 and the appropriate congressional committees1 and make publicly available1 a report on the activities funded through the grant for each fiscal year covered by the report1 including-- 7#a7 the allocation of funds for activities under subsection 7e7 versus activities under subsection 7f72 7#b7 a description of the research conducted by the grantee under subsection 7e77#a77;,a71 including the results of such research2 7#c7 an up-to-date version of the strategic plan developed under subsection 7e77#a77;,b72 and 7#d7 a description of the co-prescribing program under subsection 7f71 including an analysis of the effectiveness of the program4 7j7 ,definitions ,in this section3 7#a7 ,appropriate congressional committees ,the term appropriate congressional committees means the ,committee on ,energy and ,commerce of the ,house of ,representatives and the ,committee on ,housing1 ,education1 ,labor1 and ,pensions of the ,senate4 7#b7 ,eligible entity ,the term eligible entity means any ,state1 any ,indian ,tribe1 the ,district of ,columbia1 or any territory of the ,united ,states4 7#c7 ,indian ,tribe ,the term ,indian ,tribe has the meaning given to such term in section #d of the ,indian ,self-,determination and ,education ,assistance ,act4 7#d7 ,opioid overdose reversal drug ,the term opioid overdose reversal drug means-- 7,a7 naloxone2 or 7,b7 any other emergency opioid antagonist approved by the ,food and ,drug ,administration to treat an opioid overdose4 7k7 ,authorization of appropriations ,to carry out this section1 there are authorized to be appropriated such sums as may be necessary for each of fiscal years #bjbb through #bjbf4 4